The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 09, 2024
Filed:
Jun. 15, 2017
Applicant:
Mayo Foundation for Medical Education and Research, Rochester, MN (US);
Inventors:
Kah-Whye Peng, Rochester, MN (US);
Stephen James Russell, Rochester, MN (US);
Mitesh J. Borad, Tempe, AZ (US);
Yumei Zhou, Rochester, MN (US);
Amber C. Miller, Eden Prairie, MN (US);
Assignee:
Mayo Foundation for Medical Education and Research, Rochester, MN (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/768 (2015.01); G01N 33/574 (2006.01); C12N 7/00 (2006.01); A61K 35/761 (2015.01); A61K 35/763 (2015.01); A61K 35/766 (2015.01); C40B 40/08 (2006.01);
U.S. Cl.
CPC ...
A61K 35/768 (2013.01); C12N 7/00 (2013.01); G01N 33/57438 (2013.01); A61K 35/761 (2013.01); A61K 35/763 (2013.01); A61K 35/766 (2013.01); C40B 40/08 (2013.01); G01N 2800/52 (2013.01);
Abstract
This document relates to methods and materials involved in treating cancer. For example, methods and materials for using one or more oncolytic viruses (e.g., one or more replicating oncolytic viruses) to treat cancer in a mammal (e.g., a human) identified as having a cancer likely to respond to oncolytic virotherapy are provided.